Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The new debit restructuring is going to make a big difference in the long term.
They did have business at the start. It was an online web site and they were trying to do something with mobile notifications of events like nightlife stuff.
None. No filing to that. Only the 8k for financing.
It is a good move. they know they need a business leader and not a scientist. Let Head focus on the product while someone else handles the business.
Thanks. For some reason TD Ameritarde does not have news from the 7th. The last one posted is from Nov 8th.
There was no mention of a meeting on the 19th in the last PR. The only date mentioned was the start of phase 2 enrollment on the or about the 17th.
multiple biopsies during any “active surveillance” or “watchful waiting” is normal.
Because MAXM is done.
So if the borrowed new money to pay off bad old money why is MAXM still around. The have a 8 month lock on converting on the new loan correct? So why is it still being diluted? The 8k basically says we borrowed new money to pay old off. So it was nothing left to pay for any new research, correct?
I was in touch with them also. easy to get hold of these places and ask about trials. I am going to get hold of Harvard also. Just cask what is available an what is coming like a patient.
They cal it a vaccine but is is really a treatment. I do not think it will stop you from getting the cancer but it slows it down so your PSA rise is stable or lower. I had the cancer and had mine removed. I would of loved to try this. One of the main treatments is watchful waiting and it would be used in those cases. I guess someday it could prevent it all together.
How could you loss money on Avid Bioservices Inc NASDAQ: CDMO?? It is a winning stock at 53 week high.
I think they would do more than 2. I think they would take any study that looks promising and they have the people to participate.
I see it as a general ad for them to cover all studies under their belt.
hold em tight and make them come get it. No need to drop to the bid.
at that .03 wall. need about 1 million shares bought to break it. I think if we can get above it we are setting a new level.
today shows how quickly this thing is going to move once news hits. A few buys and it will move. everyone is holding tight.
I have been asking the same thing lately about these end of day sells. Why would anyone sell at less than the BID for any reason?
exactly. He lost his $100 and cries every day. The stock market is not for everyone, especially the pinks. How do you think the company has been around all these years with no income?
and on to what? i am a simple investor, nothing to hide here. Google me I come up.
I think it is not moving cause no one is willing to sell. the bid keeps creeping up.
We have a really great drug on our hands here. It has already had good results from Phase 1 and I think will show better results in Phase two.
You are right. I missed that part and that is good news. Hopefully they do it sooner than 2 years. https://www.fda.gov/forindustry/developingproductsforrarediseasesconditions/howtoapplyfororphanproductdesignation/default.htm
I do not see that as massive dilution in the big picture.
Even Amazon has a hard time posting a profit. Not sure why LC thinks they should be in profit mode already when they are development company. they have to raise funds and they are doing it like any other development company. We are all betting on them getting approval and showing good results along with keeping the process going. They have to borrow to do that. No other way to get the money unless someone just gives it to you. Also the continued business statement is not unique it is in almost every statement made by a development company. Since they do not have revenue they could fold at anytime if they can not find funding. No secret there.
Of course they have to sell shares and get loans. They are not a revenue company. It has to be paid for. They are very tight on issuing shares and doing it only as they really need too. Some of the financials did improve and it is all about trying to get approval and the money issues go away overnight. That is why people buy shares and other loan cash. There are no companies that are in development only making money. They are all funded some how. Also everyone of them could stop business overnight. OBMP has been around years and they will continue to do what they are doing.
No breaking news. Nothing new. Nothing really bad either. Sure standard verbiage about continuing operations but that is standard stuff for all these startups. They have had to say that since they first started. No surprises. We just need news that phase 2 is enrolling and rolling.
Nothing between here and .03 cents.
Need a timely 10q no matter what is in it. Need them to work to get better financial agreements. Need to get back on the OTCQB. Need to start the trials on time tomorrow. Need to closeout the Mexico deal, good or bad. Need to start doing at least a monthly update status report.
Man I wish we could bust that .03 barrier. Once that happens we will be in good shape.
Mexico shares are in escrow right? I think they will be able to get those back based on failure of the contract.
We do need them to get off the pink and back to OTC. That will make a big difference.
Everything is at a stand still.
who has 500,000 on the ask at .0251
Both Trials are still moving forward as planned. I expect to see an update soon. Hopefully by end of next week.
emailed Andrew this morning. Stated I hope there is an update PR soon.
Suppose to start enrollment 15th of this month.
Up 22% and now we need to tear down the .03 wall once and for all.
Very doubtful if they will charge participates. They may actually pay them something to come.
More than a year
Estimated Study Start Date : August 15, 2018
Estimated Primary Completion Date : August 15, 2020
Estimated Study Completion Date : August 15, 2022